1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuries
    Meeting Abstract

    Velardi, E.; Tsai, J. J.; Radtke, S.; Cooper, K.; Argyropoulos, K.; Jae-Hung, S.; Jenq, R. R.; Hanash, A. M.; Moore, M.; Kiem, H. P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Domination of the gut microbiota with enterococcus species early after allogeneic bone marrow transplantation is an important contributor to the development of acute graft-versus-host disease (GHVD) in mouse and man
    Meeting Abstract

    Stein-Thoeringer, C.; Peled, J. U.; Lazrak, A.; Slingerland, A. E.; Shono, Y.; Staffas, A.; Gomes, A.; Argyropoulos, K.; Docampo, M.; Xavier, J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Senescence after growth arrest: A mechanism by which CDK4/6 inhibitors can mediate their activity suppressing tumor progression
    Meeting Abstract

    Koff, A.; Klein, M. E.; Dickson, M. A.; Antonescu, C.; Qin, L. X.; Dooley, S. J.; Schwartz, G.; Crago, A. M.; Singer, S.; Tap, W. D.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): Two open-label, non-comparative, randomised, phase 2 trials
    Journal Article

    D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Atkins, J.; Milhem, M. M.; Jahagirdar, B. N.; Antonescu, C. R.; Horvath, E.; Tap, W. D.; Schwartz, G. K.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
    Journal Article

    Lindeman, N. I.; Cagle, P. T.; Aisner, D. L.; Arcila, M. E.; Beasley, M. B.; Bernicker, E. H.; Colasacco, C.; Dacic, S.; Hirsch, F. R.; Kerr, K.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Urothelial neoplasms in pediatric and young adult patients: A large single-center series
    Journal Article

    Saltsman, J. A.; Malek, M. M.; Reuter, V. E.; Hammond, W. J.; Danzer, E.; Herr, H. W.; LaQuaglia, M. P.
    Journal of Pediatric Surgery (2018)

    Fulltext@MSK | Save
  • The emerging significance of secondary germline testing in cancer genomics
    Journal Article

    Mandelker, D.; Zhang, L.
    Journal of Pathology (2018)

    Fulltext@MSK | Save
  • Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
    Journal Article

    Lindeman, N. I.; Cagle, P. T.; Aisner, D. L.; Arcila, M. E.; Beasley, M. B.; Bernicker, E. H.; Colasacco, C.; Dacic, S.; Hirsch, F. R.; Kerr, K.; more...
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save